Using the multiphaseoptimizationstrategy (MOST) to optimize an intervention to increaseCOVID-19testing for Black and Latino/Hispanicfrontlineessentialworkers
Project Number1U01MD017418-01
Former Number1U01MH129914-01
Contact PI/Project LeaderGWADZ, MARYA
Awardee OrganizationNEW YORK UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY. The proposed study responds to RFA-OD-21-008 which calls for community-engaged
interventions to support COVID-19testing in underserved and vulnerable populations. Among those at highest
risk for exposure to COVID-19 is the large population of frontlineessentialworkers (FEW) in lower status
occupations (e.g., retail, in-home health care), among whom Black and Latino/Hispanic (BLH) persons are
over-represented. The CDC recommends testing for all those experiencing symptoms of COVID-19. For those
not vaccinated, testing is recommended after exposure to individuals with a COVID-19 diagnosis, and regular
COVID-19 screening testing is recommended even when asymptomatic for those with frequent close contact
with others in indoor settings such as FEW. However, BLH-FEW experience serious impediments to COVID-19testing at individual/attitudinal- (e.g., lack of knowledge of guidelines, distrust), social- (e.g., social norms), and
structural-levels of influence (e.g., poor access to testing). Indeed, testing rates are lower among BLH than
White populations and only 25-50% of BLH-FEW are currently vaccinated. The proposed community-engaged
study is led by a collaborative team at New York University and the Northern Manhattan Improvement
Corporation (NMIC). Its main goal is to optimize a behavioral intervention to boost COVID-19testing rates for
BLH-FEW. Consistent with RFA-OD-21-008, the proposed study uses the multiphaseoptimizationstrategy
(MOST) framework to test four candidate intervention components grounded in our past research. The
candidate components are informed by critical race theory and guided by the theory of triadic influence, are
brief or do not require substantial staff time, and will be tested in a highly efficient factorial experimental design.
They are A) motivational interview counseling, B) a text message component grounded in behavioral
economics, C) peer education, and D) access to testing (via navigation to a test appointment vs. a self-test kit).
All participants receive the standard of care, namely, health education on COVID-19testing, and referrals. The
specific aims of the study are to: identify which of four candidate components contribute meaningfully to
improvement in the primary outcome, COVID-19testing with medical confirmation; the most effective
combination of components will comprise the “optimized” intervention (Aim 1), identify mediators (e.g., distrust,
access) and moderators (e.g., sociodemographic characteristics) of the effects of each component (Aim 2),
and use a mixed-methods approach to explore relationships among barriers to, facilitators of, and uptake of
COVID-19testing and COVID-19 vaccination (Aim 3). Participants will be N=448 BLH-FEW who have not been
tested for COVID-19 in the past six months and who are not vaccinated for COVID-19, randomly assigned to
an intervention condition, and assessed at 6- and 12-weeks post-baseline; N=50 participants will engage in
qualitative in-depth interviews. We will also uncover, describe, and plan for implementation issues so the
optimized intervention can be rapidly scaled up by NMIC and other community-based organizations.
Public Health Relevance Statement
PUBLIC HEALTH RELEVANCE STATEMENT: COVID-19testing is essential to controlling the COVID-19
pandemic to break transmission chains and reduce community transmission. However, Black and
Latino/Hispanic populations in lower status frontlineessential occupations such as food preparation, retail,
building maintenance, personal services, and in-home health care have serious barriers to COVID-19testing
and, therefore, insufficient testing rates. The proposed study will use the multiphaseoptimizationstrategy
framework to address the problem of low COVID-19testing rates for this population: We will test the effects of
four distinct candidate intervention components and then create an efficient multicomponent made up of the
most effective combination of the components that can be rapidly scaled up in community settings to boost
COVID-19testing rates.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAgeAltruismAppointmentBehavior TherapyBlack raceCOVID-19COVID-19 diagnosisCOVID-19 disparityCOVID-19 pandemicCOVID-19 screeningCOVID-19 severityCOVID-19testingCOVID-19 vaccinationCenters for Disease Control and Prevention (U.S.)CharacteristicsCognitiveCommunitiesCounselingDataDiagnostic Reagent KitsDiagnostic testsEducationEmotionsEssential workerExperimental DesignsExposure toFrightFutureGoalsGuidelinesHealthHealth educationHispanicHispanic PopulationsHomeHome Care ServicesIndividualInterventionInterviewJointsKnowledgeLanguageLatinoMaintenanceMediator of activation proteinMedicalMethodsNew YorkNew York CityOccupationsParticipantPersonsPopulationQualitative ResearchRaceRandomizedReadinessResearchResearch DesignSARS-CoV-2 exposureServicesSick LeaveSiteSpecific qualifier valueSymptomsTestingText MessagingTimeTriad Acrylic ResinUnderserved PopulationUniversitiesVaccinatedVulnerable Populationsbasebehavioral economicscommunity settingcommunity transmissioncoronavirus diseasedistrustexperiencefood preparationhealth beliefhigh riskimplementation barriersimplementation interventionimprovedmotivational enhancement therapymulti-component interventionmultiphaseoptimizationstrategypandemic diseasepeerprimary outcomepublic health relevanceracial and ethnic disparitiesscale upscreeningself testingsocialsocial normsociodemographicsstandard of caretext messaging interventiontheoriestransmission processunvaccinateduptake
National Institute on Minority Health and Health Disparities
CFDA Code
310
DUNS Number
041968306
UEI
NX9PXMKW5KW8
Project Start Date
01-January-2022
Project End Date
30-November-2023
Budget Start Date
01-January-2022
Budget End Date
30-November-2022
Project Funding Information for 2022
Total Funding
$1,200,348
Direct Costs
$780,385
Indirect Costs
$419,963
Year
Funding IC
FY Total Cost by IC
2022
NIH Office of the Director
$1,200,348
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U01MD017418-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U01MD017418-01
Patents
No Patents information available for 1U01MD017418-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U01MD017418-01
Clinical Studies
No Clinical Studies information available for 1U01MD017418-01
News and More
Related News Releases
No news release information available for 1U01MD017418-01
History
No Historical information available for 1U01MD017418-01
Similar Projects
No Similar Projects information available for 1U01MD017418-01